These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 7528385)

  • 1. The assessment of medical treatment for benign prostatic hyperplasia (BPH).
    Roehrborn CG
    Prog Clin Biol Res; 1994; 386():175-90. PubMed ID: 7528385
    [No Abstract]   [Full Text] [Related]  

  • 2. Single-blind, randomized controlled study of the clinical and urodynamic effects of an alpha-blocker (naftopidil) and phytotherapy (eviprostat) in the treatment of benign prostatic hyperplasia.
    Kaplan SA
    J Urol; 2005 Sep; 174(3):1011. PubMed ID: 16094031
    [No Abstract]   [Full Text] [Related]  

  • 3. [Drug therapy of benign prostatic hyperplasia].
    Vahlensieck W; Fabricius PG; Hell U
    Fortschr Med; 1996 Nov; 114(31):407-11. PubMed ID: 9036092
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single-blind, randomized controlled study of the clinical and urodynamic effects of an alpha-blocker (naftopidil) and phytotherapy (eviprostat) in the treatment of benign prostatic hyperplasia.
    Yamanishi T; Yasuda K; Kamai T; Tsujii T; Sakakibara R; Uchiyama T; Yoshida K
    Int J Urol; 2004 Jul; 11(7):501-9. PubMed ID: 15242359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medical management of benign prostatic hyperplasia other than with hormones or alpha blockers.
    Fitzpatrick JM; Dreikorn K; Habib F; Mebust WK; Perrin P; Schulze HK
    Prog Clin Biol Res; 1994; 386():303-9. PubMed ID: 7528399
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical results with alpha-blockers in patients with symptomatic benign prostatic hyperplasia.
    Mensink HJ
    Prog Clin Biol Res; 1994; 386():285-9. PubMed ID: 7528396
    [No Abstract]   [Full Text] [Related]  

  • 7. Treatment options in benign prostatic hypertrophy.
    Stone NN
    Hosp Pract (Off Ed); 1992 Oct; 27(10A):85-8, 91-2. PubMed ID: 1383248
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Established and upcoming new options in medical therapy for benign prostatic hyperplasia].
    Schlenker B; Beer AM; Gratzke C; Tilki D; Seitz M; Stief CG; Reich O
    MMW Fortschr Med; 2009 Oct; 151(41):33-6. PubMed ID: 19891182
    [No Abstract]   [Full Text] [Related]  

  • 9. [A clinical trial of the treatment of patients with benign prostatic hyperplasia using the alpha 1-adrenoblocker alfuzosin].
    Lopatkin NA; Perepanova TS
    Urol Nefrol (Mosk); 1997; (5):14-6. PubMed ID: 9412005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Benign prostatic hyperplasia: medical therapy].
    Schlenker B; Gratzke C; Weidlich P; Seitz M; Reich O; Stief CG
    MMW Fortschr Med; 2007 Aug; 149(33-34):29-31; quiz 32. PubMed ID: 17912863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Non surgical treatment of benign prostatic hypertrophy].
    Martini E; Vaggi L; Rucci A; Di Clemente L
    J Urol (Paris); 1993; 99(6):278-82. PubMed ID: 7516366
    [No Abstract]   [Full Text] [Related]  

  • 12. Pharmacological management of benign prostatic hyperplasia.
    Samkange C; Bhagat K
    Cent Afr J Med; 2000 Aug; 46(8):224-8. PubMed ID: 11317596
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Drug treatment options in prostatic hyperplasia].
    Hauri D
    Praxis (Bern 1994); 1997 Sep; 86(38):1463-6. PubMed ID: 9381047
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Current drug therapy of benign prostatic hyperplasia].
    Schmidbauer CP; Madersbacher S
    Wien Med Wochenschr; 1996; 146(8):161-4. PubMed ID: 8767400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Alfuzosin in benign prostatic hyperplasia. A new principle is evaluated. Report of a study].
    Fortschr Med Suppl; 1995; 166():1-12. PubMed ID: 7537599
    [No Abstract]   [Full Text] [Related]  

  • 16. [Non-surgical treatment of benign prostatic hypertrophy].
    Martini E; Vaggi L; Rucci A; Di Clemente L
    J Chir (Paris); 1994 Oct; 131(10):445-9. PubMed ID: 7532181
    [No Abstract]   [Full Text] [Related]  

  • 17. [Non-surgical treatment of prostatic hyperplasia].
    Srougi M
    AMB Rev Assoc Med Bras; 1990; 36(1):11-4. PubMed ID: 1705045
    [No Abstract]   [Full Text] [Related]  

  • 18. Medical management of benign prostatic hyperplasia: a review.
    Magoha GA
    East Afr Med J; 1996 Jul; 73(7):453-6. PubMed ID: 8918007
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Urology. Benign prostatic hyperplasia].
    Wisard M; Leisinger HJ
    Rev Med Suisse; 2005 Jan; 1(2):173-4, 176. PubMed ID: 15773221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of combination medical therapy in benign prostatic hyperplasia.
    Greco KA; McVary KT
    Int J Impot Res; 2008 Dec; 20 Suppl 3():S33-43. PubMed ID: 19002123
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.